default author photo

Florian Guisier

Normandie Université

SCHOLARLY PAPERS

3

DOWNLOADS

157

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Real-World Efficacy and Safety of Combination Nivolumab Plus Ipilimumab for Untreated, Unresectable, Pleural Mesothelioma: The Meso-Immune (Gfpc 04-2021) Trial

Number of pages: 27 Posted: 02 Feb 2024
Olivier Bylicki, Florian Guisier, Arnaud Scherereel, Catherine Daniel, Aurélie Swalduz, Emmanuel Grolleau, Marie Bernadi, Stéphane Hominal, Jean.Briac Prevost, Guillaume Pamart, Marie.Hèlene Marques, Nicolas Cloarec, Simon Deshayes, Judith Raimbourg, Remi Veillon, Youssef Oulkhouir, Clarisse Audigier-Valette, Fabien Subtil, Christos Chouaïd and Laurent Greillier
affiliation not provided to SSRN, Normandie Université, University of Lille, PSL Research University - Institut Curie, University of Claude Bernard Lyon 1 - Centre Léon Bérard, Lyon Sud Hospital - Civils Hospices of Lyon, Institut d'Administration des Entreprises d'Aix-en-Provence (IAE Aix), Centre Hospitalier Pierre Bénite, Clinique Ambroise Paré, University of Strasbourg, Groupe Hospitalier du Havre, Centre Hospitalier Henri Duffaut, University of Caen Normandie - Centre Hospitalier - CHU de Caen, Université de Nantes, University of Bordeaux - CHU de Bordeaux, University of Angers - CHU Angers, CHITS Sainte Musse, Université Lyon 1, Centre Hospitalier Intercommunal de Créteil and Aix-Marseille University
Downloads 72 (875,328)

Abstract:

Loading...

pleural mesothelioma, Immunotherapy, real-world data, survival, safety

2.

Brief Report: Carboplatin, Weekly Paclitaxel and Pembrolizumab in Elderly Patients for Advanced Non-Small Cell Lung Cancer: Real-World Data

Number of pages: 19 Posted: 20 Mar 2024
Guillaume Rousseau, Edouard Dantoing, Bénédicte Léturgie, Julie Tillon-Strozyk, Nicolas Delberghe, Antoine Gregoire, Suzanna Bota, Romain Corre, LUC THIBERVILLE and Florian Guisier
CHU Rouen, CHU Rouen, CHU Rouen, CHU Rouen, affiliation not provided to SSRN, affiliation not provided to SSRN, CHU Rouen, affiliation not provided to SSRN, CHU Rouen and Normandie Université
Downloads 54 (1,031,043)

Abstract:

Loading...

Non-small cell lung cancer, immune checkpoint inhibitors, Immunotherapy, elderly, Real-World Data.

3.

A multicenter phase 2 study evaluating Denosumab in combination with Nivolumab as second-line therapy for patients with stage IV non-small–cell lung cancer with bone metastases, DENIVOS-GFPC 06-2017

Number of pages: 21 Posted: 28 Apr 2026
Chantal Decroisette, Isabelle Monnet, Tristan Delory, Charles Ricordel, Axelle Demaegdt, Nicolas Paleiron, Lionel Falchero, Margaux Geier, gregoire Justeau, Marie Bernadi, Virgile Gazaille, Roland Schott, Sabine Vieillot, Pierre-Alexandre Hauss, Sophie Bayle, Melissa Petrier, Florian Guisier, Christos Chouaïd and Laurent Greillier
Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, Centre Hospitalier Intercommunal de Créteil, Centre Hospitalier Pierre Bénite - Clinical Research Unit, CHU Rennes, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, CHU de Brest, University of Angers - CHU Angers, Institut d'Administration des Entreprises d'Aix-en-Provence (IAE Aix), affiliation not provided to SSRN, Institut de cancérologie Strasbourg Europe ICANS, Centre Hospitalier de Perpignan, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Normandie Université, Centre Hospitalier Intercommunal de Créteil and Aix-Marseille University
Downloads 31 (1,424,331)

Abstract:

Loading...

non-small cell lung cancer, Bone metastasis, immune checkpoint inhibitor, anti-resorptive agent, skeletal-related events